| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |